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Purpose: We aimed to evaluate the anatomical and functional outcomes of posterior 
intravaginal slingplasty (P-IVS) for the treatment of a vaginal vault or uterine prolapse 
(VP/UP).
Materials and Methods: This was a 12-month prospective, multicenter, observational 
study. Women aged over 30 years who presented with stage II or greater VP/UP under-
went P-IVS by four urologists at four university hospitals. Preoperatively, pelvic exami-
nation by use of the Pelvic Organ Prolapse Quantification (POP-Q) system, the Pelvic 
Floor Distress Inventory (PFDI) questionnaire, the 3-day frequency volume chart, and 
uroflowmetry were completed. At the 12-month follow-up, changes in the POP-Q, PFDI, 
frequency volume chart, and uroflowmetry parameters were assessed. Cure was de-
fined as VP/UP stage 0 and improvement as stage I.
Results: The cure and improvement rates among the 32 women were 65.6% and 34.4%, 
respectively. All subscale scores of the Urinary Distress Inventory, the general subscale 
score of the Pelvic Organ Prolapse Distress Inventory, and the rectal prolapse subscale 
score of the Colo-Rectal-Anal Distress Inventory were significantly improved. There 
were no significant changes in the frequency volume chart or uroflowmetry parameters. 
There was one case of surgery-related transfusion.
Conclusions: Trans-vaginal repair by P-IVS is an effective and safe procedure for restor-
ing the anatomical defect and improving the associated pelvic floor symptoms in women 
with VP/UP.
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INTRODUCTION
Pelvic organ prolapse (POP) is a common condition that has 
a negative effect on a woman’s quality of life. It is estimated 
that approximately 32% of the female population aged ≥ 
18 years in Korea has some degree of POP [1]. The preva-
lence of any prolapse was 2.0% in women aged 20 to 29 
years, but in those aged over 50 years, it increased to 57.5%. 
Because POP is an age-related condition, its prevalence is 
expected to increase with the aging of the population.
　Vaginal apical prolapse, vaginal vault or uterine pro-
lapse (VP/UP), is a complex condition commonly associated 
with other organ defects such as cystocele, rectocele, or en-
terocele in nearly 75% of affected patients [2]. The clinical 
presentation varies, with various effects on urinary, bowel, 
and sexual functions. Even if incontinence is not a present-
ing complaint, it must be assessed after the reduction of the 
prolapse with a pessary or other means of support. Thus, 
successful treatment for VP/UP depends not only on the re-
storation of the anatomical abnormality but also on com-
prehensive management of the combined dysfunction, in-
cluding all potential vaginal support defects and urinary, 
bowel, and sexual dysfunctions.
　The surgical management of apical prolapse requires an 
apical suspension procedure. For the last decades, VP/UP 
has been treated by several forms of trans-vaginal or 
trans-abdominal procedures, such as sacrospinous colpo-
pexy or abdominal sacral colpopexy. However, morbidity Korean J Urol 2010;51:187-192
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TABLE 1. Patient characteristics (n=32)
Variables Values
Age (years, Mean±SD)
BMI (kg/m
2, Mean±SD)
Vaginal delivery (n=27, Mean±SD)
Menopausal status 
　Post-menopause (n, %)
　Estrogen replacement (n, %)
Hysterectomy (n, %) 
Frequency volume chart 
　Micturition episode/24 hours (Mean±SD)
　Nocturia episode/24 hours (Mean±SD)
Uroflowmetry
　Maximal flow rate (ml/sec, Mean±SD)
　Post voided residuals (ml, Mean±SD)
56.2±11.4 
24.4±3.4
2.7±1.6
21 (65.6%)
20 (62.5%)
11 (34.4%)
8.5±2.9 
1.4±0.9 
15.8±8.0
49.7±65.6 
BMI: body mass index
and a high recurrence rate necessitated less morbid and 
more effective therapeutic methods. In trials of minimally 
invasive and less morbid surgical techniques, Petros [3] in-
troduced infracoccygeal sacropexy with intravaginal sling-
plasty (Tyco Healthcare, Norwalk, USA), giving rise to pos-
terior intravaginal slingplasty (P-IVS) based on the in-
tegral theory in 1997 [4]. The most critical aspect of this pro-
cedure is to restore the prolapsed upper vagina to a normal 
anatomical position by means of uterosacral ligament 
suspension. 
　We conducted the present study to evaluate the ther-
apeutic efficacy and safety of P-IVS for restoring the ana-
tomical defect of the VP/UP and for improving the asso-
ciated pelvic floor symptoms.
MATERIALS AND METHODS
1. Participants
A total of 40 women aged over 30 years presenting with 
stage≥II VP/UP underwent P-IVS by four urologists at 
four university hospitals. Exclusion criteria included preg-
nancy or contemplating pregnancy during the study peri-
od, severe vaginal atrophy, history of pelvic irradiation 
therapy, and high risk for surgery. The study was per-
formed in accordance with the principles of the Declaration 
of Helsinki, and written informed consent was obtained 
from all patients before surgery.
2. Assessment
The baseline demographic data collected included age, 
body mass index (BMI), obstetric and gynecologic history, 
and medical and surgical history. Preoperatively, all sub-
jects underwent a pelvic examination in the seated semi- 
lithotomy position with a Valsalva maneuver. The POP 
quantification (POP-Q) standard scoring system and 3x3 
grid system [5] were adopted for staging and recording the 
9 points of the POP-Q system. In cases presenting with low-
er urinary tract symptoms (LUTS), including stress uri-
nary incontinence (SUI), a multi-channel urodynamic 
study was performed with reduction of the prolapse. The 
Pelvic Floor Distress Inventory (PFDI) score [6], 3-day fre-
quency volume chart (FVC), and maximal flow rate (MFR) 
with post-void residuals (PVR) were also evaluated. At the 
12-month postoperative visit, the POP-Q stage and the 9 
points were evaluated to assess the anatomical results. 
Cure of VP/UP was defined when the postoperative POP-Q 
system point C was found to be stage 0, i.e., the quantitation 
value for point C was ≤−[total vaginal leugth (TVL)-2] cm. 
Improvement was defined as stage I, i.e., its quantitation 
value was ＜−1 and ＞−[TVL-2] cm. Failure was assigned 
to postoperative POP-Q stage II or greater, i.e., its quanti-
tation value was ≥−1 cm. Surgical outcomes of the com-
bined compartment prolapses were assessed similarly, 
which defined cure as stage 0, improvement as stage I, and 
failure as stage II or greater, as described in the POP-Q sys-
tem [5]. Postoperative changes in the PFDI score, FVC, 
MFR, and PVR were evaluated to assess the functional 
outcomes. Intraoperative and postoperative complications 
were also evaluated. 
3. Procedure
The surgeries were performed with the patient in the lith-
otomy position under spinal or general anaesthesia. The 
procedure followed the methods introduced by Papa Petros 
[7] with a tunnelling device (Tyco Healthcare, Norwalk, 
USA) and polypropylene tape (Tyco Healthcare, Norwalk, 
USA). For patients who had concomitant surgeries, addi-
tional procedures were performed after closure of the P-IVS 
wound. Vaginal packing and a urethral catheter were left 
in place for 48 hours. Intravenous antibiotics were given 
postoperatively for 24 hours, followed by oral treatment for 
14 days.
4. Analysis
Postoperative changes in the POP-Q stage, PFDI, FVC, 
MFR, and PVR were evaluated. Statistical significance 
was determined by using a Wilcoxon signed rank test or a 
Student's t-test (paired) according to the normality 
assumption. Comparison of the outcomes between women 
with vault prolapse and those with uterine prolapse was 
performed by using the Mann-Whitney U or chi-square 
test. All statistical analyses were performed with SPSS 
17.0 software (SPSS, Chicago, USA). A p-value of ＜0.05 
was considered to be statistically significant.
RESULTS
Thirty-two of the 40 women were followed up for 12 months 
postoperatively. The women’s average age was 56.2 years 
and their average BMI was 24.4 kg/m
2. Eleven (34.4%) 
women had a prior hysterectomy (Table 1). The average 
time for surgery was 68.5±33.9 min [71.9±33.7 for VP and 
66.7±4.5 for UP (p=0.502)]. Average hospital stay was 
4.6±1.9 days [4.8±1.7 for VP and 4.5±2.1 for UP (p=0.416)]. 
Concomitant surgeries were performed in 21 (65.6%) wom-
en: 16 (50.0%) midurethral slings (MUS), 14 (43.7%) ante-Korean J Urol 2010;51:187-192
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TABLE 2. Operative data (n=32)
Variables Values
Anesthesia (n, %)
　Spinal
　General
Mesh length (cm, Mean±SD)
Operation time (min, Mean±SD)
Hospital stay period (days, Mean±SD)
Combined surgery (n=21)
　Midurethral sling＋cystocele repair
　Midurethral sling＋cystocele repair＋PC
　Midurethral sling＋PC
　Midurethral sling
　Cystocele repair
　Cystocele repair＋PC
　PC
Other (hemorrhoidectomy)
4 (12.5%)
28 (87.5%)
16.4±10.2
68.5±33.9
4.6±1.9
7 (21.9%)
4 (12.5%)
1 (3.1%)
4 (12.5%)
2 (6.2%)
1 (3.1%)
1 (3.1%)
1 (3.1%)
PC: posterior colporrhaphy
TABLE 3. Changes in the POP-Q stage from baseline to 12 months postoperatively (n=32)
POP-Q stage
Anterior prolapse Vault/uterine prolapse Posterior prolapse
Baseline 12 months Baseline 12 months Baseline 12 months
0
I
II
III
IV
0
2 (6.3%)
16 (50.0%)
12 (37.5%) 
2 (6.3%)
22 (68.8%) 
4 (12.5%) 
6 (18.8%)
0
0
0
0
24 (75.0%)
5 (15.6%)
3 (9.4%)
21 (65.6%)
11 (34.4%)
0
0
0
3 (9.4%)
5 (15.6%)
18 (56.3%)
4 (12.5%)
2 (6.3%)
28 (87.5%)
3 (9.4%)
1 (3.1%)
0
0
POP-Q: Pelvic Organ Prolapse Quantification
TABLE 4. Changes in the 9 points of the POP-Q system from base-
line to 12 months postoperatively (n=32)
POP-Q
points (cm)
Baseline 12 months p-value
Aa 
Ba 
C 
gh 
Pb 
Tvl 
Ap 
Bp 
D (n=21)
a
−0.19±2.40
　1.37±2.22
　1.08±2.72
　4.18±1.49
　2.78±0.88
　8.42±1.04
−1.22±2.14
　0.09±2.25
−0.24±1.79
−2.37±1.16
−2.34±1.15
−6.09±1.16
　3.50±1.28
　3.01±0.76
　8.26±0.89
−2.78±0.61
−2.81±0.59
−7.19±1.19
＜0.001
＜0.001
＜0.001
　0.004
　0.016
　0.365
　0.001
＜0.001
＜0.001
Data were presented Mean±SD. POP-Q: Pelvic Organ Prolapse 
Quantification, 
a: for women who had not undergone hyster-
ectomy
TABLE 5. Change in the Pelvic Floor Distress Inventory scale from 
baseline to 12 months postoperatively
Baseline 12 months p-value
UDI
　Obstructive/discomfort
　Irritative 
　Stress 
POPDI
　General 
　Anterior 
　Posterior 
CRADI
　Obstructive 
　Incontinence
　Pain/irritation 
　Rectal prolapse 
45.5±19.3
34.2±19.7
33.3±25.3
49.2±22.6
46.8±26.3
34.8±27.6
34.8±27.6
17.0±17.8
20.9±15.7
12.5±16.4
28.8±19.7
23.3±17.9
12.7±20.7
24.1±22.0
35.7±20.8
30.2±25.9
30.1±25.9
21.9±18.9
18.9±15.6
7.7±13.4
　0.005
　0.011
＜0.001
＜0.001
　0.105
　0.655
　0.655
　0.199
　0.609
＜0.001
Data were presented Mean±SD. UDI: Urinary Distress Invento-
ry, POPDI: Pelvic Organ Prolapse Distress Inventory, CRADI: 
Colo-Rectal-Anal Distress Inventory
rior vaginal wall repairs, 7 (21.9%) posterior colpor-
rhaphies, and 1 hemorrhoidectomy (Table 2).
　In the preoperative pelvic examination, 24 of the 32 pa-
tients (75.0%) had stage II VP/UP, 5 (15.6%) had stage III, 
and 3 (9.4%) had stage IV. At 12 months postoperatively, 
the cure rate of apical prolapse was 65.6% (21/32) and the 
improvement rate was 34.4% (11/32) [63.6% (7/11) for VP 
and 66.7% (14/21) for UP (p=1.000)]. For anterior vaginal 
wall prolapse, the cure rate was 68.8% (22/32) and the im-
provement rate was 12.5% (4/32). For posterior vaginal 
wall prolapse, the cure rate was 87.5% (28/32) and the im-
provement rate was 9.4% (3/32). During 12 months of fol-
low-up, 6 patients had recurrent anterior prolapse and 1 
had recurrent posterior prolapse. The anatomical results 
of the apical, anterior, and posterior prolapses are sum-
marized in Table 3. There was no new development of ante-
rior wall prolapse. The average level of point C changed 
from ＋1.08 (±2.72) to −6.09 (±1.16) (p＜0.001). The changes 
in the 9 points of the POP-Q system from baseline and to 
12 months postoperatively are summarized in Table 4.
　After MUS for symptomatic or occult SUI, 15 of 16 women 
reported no leakage. No women experienced de novo SUI. 
In terms of the PFDI scale, the obstructive/discomfort, irri-
tative, and stress subscale scores of the Urinary Distress 
Inventory were significantly improved. For the POP 
Distress Inventory, the general subscale score was im-
proved but the anterior and posterior subscale scores were 
not significantly changed. For the Colo-Rectal-Anal Dis-
tress Inventory, only the rectal prolapse subscale score was 
significantly improved (Table 5). There were no statisti-
cally significant postoperative changes in the average Korean J Urol 2010;51:187-192
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MFR (from 15.8±8.0 ml/s to 14.6±8.1 ml/s, p = 0.379) or PVR 
(from 49.7±65.6 ml to 22.3±27.4 ml, p=0.230). Preoper-
atively, 2 patients showed an obstructive uroflowmetry 
pattern and 3 patients had large PVRs (≥150 ml). After 
successful correction of the anatomical defect, their uro-
flowmetry patterns returned to normal, and PVRs were re-
duced to less than 100 ml. Based on the 3-day FVC, fre-
quency, nocturia, and functional bladder capacity were not 
significantly changed.
　There was one case of increased intraoperative bleeding. 
One woman required transfusion with 2 pints of blood and 
the bleeding was controlled conservatively. No other intra- 
or postoperative complications were observed, including 
rectal or bladder perforation, wound infection, or mesh 
erosion.
DISCUSSION
Our study prospectively evaluated the anatomical and 
functional outcomes of P-IVS for apical prolapse. We re-
ported data on 32 patients undergoing P-IVS for VP/UP. 
The anatomical cure rate was 65.6% and the improvement 
rate was 34.4% at 12 months after surgery with a success 
rate of 100%. In the initial preliminary results on P-IVS, 
success rates of over 90% were reported by Papa Petros [7] 
and Farnsworth [8]. In recent studies, success rates ranged 
from 95% to 98% with short-term and medium-term fol-
low-up [9,10]. In a randomized controlled trial, the ob-
jective success rate of P-IVS was 95%, which was com-
parable to that of sacrospinous ligament fixation [11]. 
Regardless of how success is defined, the literature con-
sistently shows an excellent success rate, suggesting that 
the P-IVS procedure is an effective treatment for restora-
tion of the apical defect.
　However, there is some evidence that the apical repair 
impacts the anterior vaginal wall prolapse. This is as-
sumed to result from a change in the vaginal axis. In pre-
vious studies, a higher rate of de novo anterior wall pro-
lapse was reported for sacrospinous ligament fixation than 
for other approaches such as abdominal sacral colpopexy 
[12,13]. During sacrospinous fixation, retroversion and fix-
ation of the vaginal apex exposes the anterior vaginal wall 
to excessive pressure, which may result in the development 
of anterior prolapse. The incidence of postoperative ante-
rior wall prolapse varies after sacrospinous fixation, rang-
ing from 11% to 92% [14,15]. Such a wide range comes from 
the heterogeneity of the studies involved, with respect to 
combined surgical procedures performed in conjunction 
with apical repair. In a randomized controlled trial, 4.8% 
of the P-IVS and 25% of the sacrospinous fixation group re-
ported having postoperative anterior vaginal wall prolapse 
[11]. In this study, there were 6 (18.8%) cases of post-
operative recurrent anterior vaginal wall prolapse. In gen-
eral, the incidence ranges from about 10% to 27% [16].
　Petros and Farnsworth introduced the P-IVS as a novel 
procedure not only for reconstruction of the anatomical de-
fect but also for improvement of the combined LUTS, 
grouped as posterior fornix syndrome [4], which comprises 
symptoms of frequency, urgency, nocturia, abnormal emp-
tying, and pelvic pain. Richardson and colleagues [17] also 
reported that POP causes bladder outlet obstruction by in-
creasing the urethral closure pressure and that women 
with POP would be expected to manifest an obstructed 
voiding pattern. Therefore, in assessing the outcomes of 
the prolapse surgery, functional outcomes should be eval-
uated in conjunction with the anatomical result. Although 
functional or symptomatic outcomes of prolapse surgery 
have been reported in a few articles, those studies often 
used nonstandardized assessment tools. In our study, 
LUTS were evaluated by means of a disease-specific ques-
tionnaire, FVC, and uroflowmetry. In terms of the PFDI, 
all of the obstructive, irritative, and stress symptoms were 
significantly improved after surgery. Also, the uroflow pat-
tern was improved and PVRs were reduced in women with 
a preoperative obstructive uroflow pattern or large PVRs 
after successful correction of their anatomical defect. 
These results show that functional outcomes are correlated 
with anatomical success.
　  De novo SUI is one of the outcomes that is evaluated in 
the study of POP. Even though it is impossible to measure 
the effect of P-IVS on SUI owing to combined anti-incon-
tinence surgeries, the incidence of de novo incontinence af-
ter P-IVS was reported in 0% to 5% of women [9,18,19]. 
Concomitant anti-incontinence surgeries were performed 
in most of the patients in our study. Postoperatively, none 
of our patients complained of de novo incontinence. One of 
16 patients who received concomitant MUS reported per-
sistent SUI after the surgery. It is suggested that massive 
vaginal prolapse may cause functional urethral ob-
struction and mask an incompetent continence mecha-
nism. Following correction of the prolapse, SUI may occur 
or persist. Therefore, examination for potential SUI with 
reduction of the prolapse is important and necessary before 
POP surgery.
　In sexually active women, postoperative vaginal short-
ening and sexual function should be considered when 
choosing the surgical options for apical prolapse, especially 
in patients who had a prior hysterectomy. Although sexual 
function was not evaluated, our study showed no sig-
nificant change in the total vaginal length after surgery 
(from 8.4 cm to 8.2 cm, p=0.197). In general, sexual dysfunc-
tion or dyspareunia is associated with the traditional pos-
terior colporrhaphy combined with an extensive levator 
ani plication due to constriction of the vaginal tube. 
Approximately 5% of women in whom the uterus was re-
moved reported dyspareunia, whereas no women reported 
the symptom when the uterus was preserved during P-IVS 
[20,21].
　There were no complications in our study except for one 
case of increased intraoperative bleeding in a woman with 
UP. She underwent combined surgeries for cystocele and 
SUI and received two pints of blood. Her hemoglobin level 
was 10.9 g/dl at the preoperative evaluation and dropped 
to 8.4 g/dl on the postoperative follow-up test 2 days after Korean J Urol 2010;51:187-192
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surgery. She had no symptoms and there was no hematoma 
or bleeding on the physical exam. Pelvic ultrasonography 
showed a small hematoma around the posterior bladder 
neck. In a review paper, the rate of transfusion after P-IVS 
was estimated to be 0% to 0.3% [22]. According to the 
Austrian registry, 7 of 577 (1.2%) patients were reported 
to have increased intraoperative bleeding [19]. This com-
plication is more related to the concomitant surgeries, es-
pecially hysterectomy, than to the procedure of P-IVS 
[18,19]. Although hematomas requiring reoperation were 
reported in 0.9% of cases [19]; generally, the bleeding could 
be managed conservatively without surgical intervention 
[10,18,19].
　Reported complications after P-IVS include mesh ero-
sion in 8%, dyspareunia in 2%, followed by hematoma in 
1%. Other complications include prolonged pain, blood 
transfusion, proctotomy, pararectal abscess, and fistula 
[23]. In terms of the mesh used in the P-IVS procedure, the 
nylon mesh initially used was replaced with polypropylene 
multifilament mesh as the result of high rates of erosions. 
Farnsworth [8] first reported an erosion rate of 10% with 
nylon tape, and the erosion rate was dropped to 0% after 
he started using polypropylene mesh. We used poly-
propylene multifilament mesh and there was no mesh 
erosion. The absence of mesh erosion in our study may have 
been due to insertion of the mesh under the rectovaginal 
fascia and the short follow-up period. According to the data 
of Luck et al, there was an 18% incidence of mesh erosion 
and it occurred late in the postoperative period [9]. Thus, 
our small study population and the short follow-up period, 
which were the main limitations of the current study, 
might have resulted in an underestimate of the rate of 
long-tem complications. Compared with the recently re-
leased Prolift system (Ethicon Women’s Health and 
Urology, Somerville, USA), the mean mesh-related compli-
cation rate of P-IVS was lower, presumably because of the 
smaller amount of mesh used [23].
　Another limitation of this study was that the outcomes 
were not only for P-IVS but also for the surgeries conducted 
in conjunction with P-IVS. Combined surgeries might con-
found the results. A stratified analysis is needed to elimi-
nate such confounding factors. However, this study was un-
der-powered to conduct stratified analysis and to detect dif-
ferences in outcomes.
CONCLUSIONS
Trans-vaginal repair by P-IVS is an effective and safe pro-
cedure for restoring the anatomical defect and improving 
the associated pelvic floor symptoms in women with 
VP/UP, as shown after 1 year of follow-up.
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